YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J.F. who wrote (20059)	11/7/2006 5:14:59 PM
From: ACAN	Read Replies (1) of 23958

jf; [XOMA] Xoma Named Biodefense Subcontractor Tuesday November 7, 4:19 pm ET Xoma Is Named Biodefense Subcontractor to Government, Eligible to Receive Up to $28.1 Million BERKELEY, Calif. (AP) -- Drug research company Xoma Ltd. said Tuesday it was named as a subcontractor to produce biodefense and infectious disease-related products for the U.S. government. The subcontract is expected to run for five years and reach as much as $28.1 million, the company said. The company said it is negotiating final terms of the agreement with the prime contract awardee, SRI International, a non profit research institute. Under its subcontract, Xoma would manufacture monoclonal antibody therapeutic agents for the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health. Shares of Xoma rose 14 cents to close at $2.37 on the Nasdaq. Earlier, shares traded as high as $2.48, edging out a previous 52-week high of $2.46. Allan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next